Birth of Parthenote Mice Directly from Parthenogenetic Embryonic Stem Cells

Citations Over TimeTop 10% of 2009 papers

Abstract

Mammalian parthenogenetic embryos are not viable and die because of defects in placental development and genomic imprinting. Parthenogenetic ESCs (pESCs) derived from parthenogenetic embryos might advance regenerative medicine by avoiding immuno-rejection. However, previous reports suggest that pESCs may fail to differentiate and contribute to some organs in chimeras, including muscle and pancreas, and it remains unclear whether pESCs themselves can form all tissue types in the body. We found that derivation of pESCs is more efficient than of ESCs derived from fertilized embryos, in association with reduced mitogen-activated protein kinase signaling in parthenogenetic embryos and their inner cell mass outgrowth. Furthermore, in vitro culture modifies the expression of imprinted genes in pESCs, and these cells, being functionally indistinguishable from fertilized embryo-derived ESCs, can contribute to all organs in chimeras. Even more surprisingly, our study shows that live parthenote pups were produced from pESCs through tetraploid embryo complementation, which contributes to placenta development. This is the first demonstration that pESCs are capable of full-term development and can differentiate into all cell types and functional organs in the body.

Related Papers

• → In vitro culture period but not the passage number influences the capacity of chimera production of inner cell mass and its deriving cells from porcine embryos(2005)19 cited
• → Effect of mesenchymal stem cells and mouse embryonic fibroblasts on the development of preimplantation mouse embryos(2016)15 cited
• → Leukemia Inhibitory Factor (LIF) Improves and Prolongs the Development of Parthenogenetic Mouse Embryos(2003)1 cited
• → Pre- and Post-implantation Development of Parthenogenetic Embryos Induced by Progesterone, and Birth of Aggregation Chimeras with Diploids in Mice(2002)
• Study on the production of chimeras derived from the transgenic embryonic stem cells by blastocysts injection(2007)